At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
Maternal SSRI use during pregnancy may be associated with altered brain development in children; however, this study cannot fully rule out contributions of confounding genetic and enviromental factors.
Fetal brain development is altered by elevated maternal distress and has adverse infant social-emotional and cognitive outcomes.
Infants exposed to maternal depression during pregnancy had significantly larger subcortical grey matter volumes and smaller midbrain volumes.
Neuroimaging studies indicate that exposure to antenatal depression may determine risk for later neuropsychiatric illness in the child.
When a woman comes in for a consultation regarding the use of medications during pregnancy, we spend most of our time reviewing the potential risks of exposure to medications during pregnancy. However, we must also [...]
We have, over the last twenty years, seen many studies assessing the risks associated with prenatal exposure to antidepressants. Â For the serotonin reuptake inhibitors (SRIs), we have a fairly large body of data regarding the [...]
Prenatal cocaine exposure or PCE occurs when a child is exposed in utero to cocaine taken by the pregnant mother. We know that cocaine exposure during pregnancy can negatively affect the pregnancy; women who use [...]
